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gen-presenting cells (APCs). We examined the effects of PrA on the
maturation and function of dendritic cells (DCs), a potent class
of APCs, and the downstream cell–cell and intracellular signaling
pathways mediating the immunosuppressive activity of PrA.
METHODS In this study, we examined the effect of PrA on DC
phenotype and compared the effects of native and PrA-treated DCs on
the proliferation and phenotype of T cells to elucidate the signaling
mechanisms of PrA-mediated immunosuppresion.
RESULTS PrA inhibited LPS-stimulated maturation of Wistar rat DCs
in vitro as reﬂected by reduced expression of costimulatory molecules
(CD80 and CD86) and reduced expression of TLR4 and NF- kB. PrA
also enhanced the release of IL-10 and decreased the release of IL-12
from DCs, but had no effect on the production of TGF-ß. In mixed
cultures, Wistar DCs pretreated with PrA impaired the proliferation of
Sprague Dawley (SD) rat T cells while promoting the expansion of SD
rat regulatory T cells (Tregs). Both oral PrA treatment and infusion of
PrA-pretreated Wistar DCs prolonged cardiac allograft survival and
expanded recipient Tregs. Donor spleen cells, but not spleen cells
from a third rat strain (DA), supported the expansion of recipient
Tregs and suppressed recipient T cell proliferation.
CONCLUSIONS We conclude that PrA triggers a tolerogenic state in
DCs that allows for the induction of alloantigen-speciﬁc Tregs and the
suppression of allograft rejection in vivo.
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OBJECTIVES Diabetic cardiomyopathy is considered one of the most
common cardiovascular complications of diabetes. However, the
exact molecular mechanisms are still obscure. This study was
designed to investigate differential expression of mRNA extracted
from myocytes of diabetic rats. Results from this study would provide
more and novel clues for further studies on diabetic cardiomyopathy.
METHODS Rats were divided into control group (Ctrl), diabetic car-
diomyopathy group (DbCM) and insulin treated group (ISN). Diabetes
in rats was induced by streptozotocin intraperitoneal injection. In ISN,
rats with diabetic cardiomyopathy received subcutaneous injection of
insulin (4-8U/day) for continuous 6 weeks. Cardiac function was
conﬁrmed by ventricular intubation hemodynamic examination. In
Ctrl and DbCM, rats received saline sc injection. Aglilent Whole
Genome Oligo Array was utilized to analyze mRNA differential
expressions in heart samples. Results of microarray were validated by
real-time PCR.
RESULTS 1510 mRNAs were found up-regulated while 1657 mRNAs
were found down-regulated in DbCM compared with Ctrl; 775 mRNAs
were found up- regulated while 614 mRNAs were found down-
regulated in ISN compared with DbCM. Notably, genes including
WDNM1 homolog, Sln (sarcolipin), Nppa (natriuretic peptide precursor
A), Mybphl (myosin binding protein H-like), Hamp (hepcidin antimi-
crobial peptide), Myl7 (myosin light chain 7), Upk1b (uroplakin 1B),
Msln (mesothelin) were found up-regulated in DbCM but corre-
spondingly down-regulated after insulin treatment in ISN. Pathway
analysis showed that pathways including PPAR, histidine metabolism,
calcium and PI3K-Akt signaling pathways were possibly involved in
DbCM. These changes were validated by RT-PCR.
CONCLUSIONS The mRNA differential expression proﬁling could
provide basis for further investigation of mechanisms of DbCM.
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OBJECTIVES 2,3,5,4’-Tetrahydroxystilbene-2-O-b-D-glucoside (TSG)
from Polygoni multiﬂori has been demonstrated to possess a variety of
pharmacological activities, including antioxidant, anti-inﬂammatory
and anti-atherosclerotic effect. The present study was undertaken to
investigate the protective effect of TSG on modulating diabetic
cardiomyopathy and the mechanisms involved heat shock protein
(HSP-70) and longevity protein SIRT1 and also modulated apoptotic
proteins Bax and Bcl-2 in diabetic cardiomyopathy.METHODS A high-fat diet and low-dose streptozotocin administration
were used to induce type 2 diabetes in Wister rats. Diabetic rats were
treated with TSG for 16 weeks. Myocardial steatosis (detected by oil
red O staining and myocardial triglyceride and diacylglycerol (DAG)
contents assay), expression of protein HSP-70 and SIRT1, heart NAD(P)
H oxidase activity, oxidative stress markers were evaluated. Changes
in the expression of cytoprotective and apoptotic proteins in the heart
of rats were also examined.
RESULTS Administration of TSG did not affect plasma glucose and
insulin levels or body weights in STZ-induced diabetic rats, but
normalized myocardial steatosis, expression of HSP-70 and SIRT1-
protein, NAD(P)H oxidase activity and oxidative stress markers, all of
which were signiﬁcantly increased in diabetic hearts. TSG also
modulated apoptotic proteins Bax and Bcl-2 in diabetic heart.
CONCLUSIONS These ﬁndings indicate that the protective mechanisms
of TSG on diabetic cardiomyopathy are involved in the alleviation of
oxidative stress injury and regulating apoptosis, partially via activation
of cyto-protective protein HSP-70 and longevity protein SIRT1.
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OBJECTIVES Cell transplantation is a promising strategy in regener-
ative medicine, the beneﬁcial effects of bone marrow mesenchymal
stem cells (BM-MSCs) in the heart diseases are widely reported,
however, MSCs in these studies are animal autogenous derived, data
are still scarce on MSCs from human umbilical cord blood(UCB-MSCs).
We investigated whether the intramyocardial xenogeneic adminis-
tration of UCB-MSCs offers beneﬁt in preserving heart function in
cTnTR141W transgenic mouse model of dilated cardiomyopathy (DCM).
METHODS Cultured UCB-MSCs, which were identiﬁed by mor-
phology, differentiation and cell surface markers, were transplanted
into cTnTR141W transgenic mouse to examine apoptosis, ﬁbrosis, vas-
culogenesis and their associated Akt pathway. We also determined
levels of VEGF and IGF-1, growth factors required for their differen-
tiation into cardiac myocytes, which also contributes in cardiac
regeneration and improved heart function. Moreover, medium pro-
duced by MSCs preconditioned under normoxia or hypoxia was
collected for subsequent in vitro assays.
RESULTS MSCs signiﬁcantly decreased chamber dilation and con-
tractile dysfunction in cTnTR141W mouse. MSCs transplanted hearts
showed a signiﬁcant decrease in cardiac apoptosis and their regula-
tion with Akt pathway. Cardiac ﬁbrosis and cytoplasmic vacuolization
in the MSCs group was signiﬁcantly lower. Importantly, the levels of
VEGF and IGF-1 were increased in MSCs transplanted hearts, sug-
gesting endogenous cardiac regeneration. In vitro, the MSC-condi-
tioned medium displayed anti-apoptotic activity in h9c2
cardiomyocytes subjected to hypoxia, further conﬁrmed the paracrine
effects of MSCs.
CONCLUSIONS UCB-MSCs preserve cardiac function after intra-
myocardial transplantation in a DCM mouse model, which may be
associated with inhibition of cellular apoptosis, inﬂammatory, up-
regulated expressions of Akt, VEGF, IGF-1 and enhanced angiogenesis.
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OBJECTIVES To explore a method to establish a rabbit model of
nonsustained ventricular tachycardia cardiomyopathy.
METHODS Fifteen New Zealand rabbits were used in this study. The
right ventricle was stimulated with mapping electrode line to create
nonsustained ventricular tachycardia by minimally invasive venous
technique without X-ray use, using a 10 polar cap of sinus electrode
inserted through modiﬁed 5F radial artery sheath and the right
anterior vena cava to the right ventricle, connecting the programming
